133 related articles for article (PubMed ID: 17636011)
61. Pioglitazone prevents mice from multiple low-dose streptozotocin-induced insulitis and diabetes.
Takamura T; Ando H; Nagai Y; Yamashita H; Nohara E; Kobayashi K
Diabetes Res Clin Pract; 1999 May; 44(2):107-14. PubMed ID: 10414929
[TBL] [Abstract][Full Text] [Related]
62. Effect of cyclosporin A on low-dose streptozotocin diabetes in mice.
Kolb H; Oschilewski M; Schwab E; Oschilewski U; Kiesel U
Diabetes Res; 1985 Jul; 2(4):191-3. PubMed ID: 3910327
[TBL] [Abstract][Full Text] [Related]
63. Analysis of 22 immunomodulatory substances for efficacy in low-dose streptozotocin-induced diabetes.
Kolb H; Oschilewski M; Oschilewski U; Schwab E; Moumé CM; Greulich B; Burkart V; Zielasek J; Kiesel U
Diabetes Res; 1987 Sep; 6(1):21-7. PubMed ID: 3319352
[TBL] [Abstract][Full Text] [Related]
64. Low dose streptozotocin diabetes after partial pancreatectomy in dogs. Histological findings in a new type of experimental diabetes.
Freyse EJ; Hahn von Dorsche H; Fischer U
Acta Biol Med Ger; 1982; 41(12):1203-10. PubMed ID: 6231789
[TBL] [Abstract][Full Text] [Related]
65. Nicotine reduces the incidence of type I diabetes in mice.
Mabley JG; Pacher P; Southan GJ; Salzman AL; Szabó C
J Pharmacol Exp Ther; 2002 Mar; 300(3):876-81. PubMed ID: 11861793
[TBL] [Abstract][Full Text] [Related]
66. Effects of chronic administration of alogliptin on the development of diabetes and β-cell function in high fat diet/streptozotocin diabetic mice.
Zhang X; Wang Z; Huang Y; Wang J
Diabetes Obes Metab; 2011 Apr; 13(4):337-47. PubMed ID: 21205126
[TBL] [Abstract][Full Text] [Related]
67. Simvastatin treatment inhibits hypoxia inducible factor 1-alpha-(HIF-1alpha)-prolyl-4-hydroxylase 3 (PHD-3) and increases angiogenesis after myocardial infarction in streptozotocin-induced diabetic rat.
Thirunavukkarasu M; Selvaraju V; Dunna NR; Foye JL; Joshi M; Otani H; Maulik N
Int J Cardiol; 2013 Oct; 168(3):2474-80. PubMed ID: 23590933
[TBL] [Abstract][Full Text] [Related]
68. Protective Effect and Potential Mechanism of Simvastatin on Myocardial Injury Induced by Diabetes with Hypoglycemia.
Li H; Zhao Q; Liu R; Yang L; Chen H; Cui X
Exp Clin Endocrinol Diabetes; 2018 Mar; 126(3):148-161. PubMed ID: 29165724
[TBL] [Abstract][Full Text] [Related]
69. Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes.
Hotta M; Tashiro F; Ikegami H; Niwa H; Ogihara T; Yodoi J; Miyazaki J
J Exp Med; 1998 Oct; 188(8):1445-51. PubMed ID: 9782121
[TBL] [Abstract][Full Text] [Related]
70. [Relationship between the expression of bcl-2 and proliferation cell nuclear antigen in islet cells and prevention of complete Freund's adjuvant on insulitis and diabetes in nonobese diabetic mice].
Yang Z; Wu H; Zhou Z
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(6):587-9. PubMed ID: 12080732
[No Abstract] [Full Text] [Related]
71. The potential role for statins in the treatment of multiple sclerosis.
Darlington CL
Curr Opin Investig Drugs; 2005 Jul; 6(7):667-71. PubMed ID: 16044661
[TBL] [Abstract][Full Text] [Related]
72. [Protection against streptozotocin-induced diabetes by cholecystokinin-octapeptide in mice].
Zhu WY; Jin YS
Sheng Li Xue Bao; 1985 Dec; 37(6):539-44. PubMed ID: 2945255
[No Abstract] [Full Text] [Related]
73. Regarding "A novel molecular mechanism to account for the action of simvastatin against limb ischemia".
Namazi H
J Vasc Surg; 2008 Jun; 47(6):1378; author reply 1378. PubMed ID: 18514858
[No Abstract] [Full Text] [Related]
74. Suppression of low-dose streptozotocin-induced diabetes by immunomodulatory lectins.
Kolb H; Oschilewski M; Schwab E; Greulich B; Roos P; Kiesel U
Diabetes Res; 1986 May; 3(4):183-6. PubMed ID: 3742941
[TBL] [Abstract][Full Text] [Related]
75. The novel anti-inflammatory compound, lisofylline, prevents diabetes in multiple low-dose streptozotocin-treated mice.
Yang Z; Chen M; Fialkow LB; Ellett JD; Wu R; Nadler JL
Pancreas; 2003 May; 26(4):e99-104. PubMed ID: 12717280
[TBL] [Abstract][Full Text] [Related]
76. The novel inosine analogue, INO-2002, protects against diabetes development in multiple low-dose streptozotocin and non-obese diabetic mouse models of type I diabetes.
Mabley JG; Pacher P; Murthy KG; Williams W; Southan GJ; Salzman AL; Szabo C
J Endocrinol; 2008 Sep; 198(3):581-9. PubMed ID: 18562629
[TBL] [Abstract][Full Text] [Related]
77. Effects of low-dose cyclosporine prophylaxis in nonobese diabetic mice.
Formby B; Miller N; Garret R; Peterson CM
J Pharmacol Exp Ther; 1987 Jun; 241(3):1106-11. PubMed ID: 3298620
[TBL] [Abstract][Full Text] [Related]
78. Antioxidant MDL 29,311 prevents diabetes in nonobese diabetic and multiple low-dose STZ-injected mice.
Heineke EW; Johnson MB; Dillberger JE; Robinson KM
Diabetes; 1993 Dec; 42(12):1721-30. PubMed ID: 8243818
[TBL] [Abstract][Full Text] [Related]
79. [Effect of the simvastatin in abdominal sepsis of diabetic rats].
Araújo-Filho I; Jácome DT; Rêgo AC; Azevedo IM; Egito ES; Medeiros AC
Rev Col Bras Cir; 2010 Feb; 37(1):39-44. PubMed ID: 20414574
[TBL] [Abstract][Full Text] [Related]
80. Simvastatin may induce insulin resistance through a novel fatty acid mediated cholesterol independent mechanism.
Kain V; Kapadia B; Misra P; Saxena U
Sci Rep; 2015 Sep; 5():13823. PubMed ID: 26345110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
